Beruflich Dokumente
Kultur Dokumente
cerebellum
cerebrum (frontal, parietal, occipital, temporal lobes, the basial ganglia, amygdala and hippocampus)
Schizophrenia tx meds-Test 2
dopamine Gaba
MRI & CT shows in schizophrenia
neurotransmitter involved in a wide variety of behaviors & emotions including pleasure. -excessive transmission in schizophrenia.
- a largely inhibitory neurotransmitter. -Distributed widely throughout the CNS -implicated in sleep and eating disorders -Low levels has also been linked to extreme anxiety
Through MRI or CT it is possible to ID gross anatomical changes in the brain: increased posterior ventricles=loss of brain tissue -In schizophrenia, cortical atrophy is detected, so there is an enlargement of the posterior ventricles.
-injected radioactive tracer travels to the brain and concentrates in area of high activity -shows dif f ering bain activity is and shows intensity of the activity & dif f ering areas f rom the normal brain
Schizophrenia tx meds-Test 2
Act as antagonists to these receptors: --->Acetylcholine (muscarinic receptors) ---> Norepinephrine (a1 receptors) ---> Histamine (H1 receptors) **also a dopamine antagonists**
-Traditional Antipsychotics Action for schizo -Traditional Antipsychotics Advantage -Traditional Antipsychotics Disadvantage
targets positive symptoms of schizophrenia b/c they dopamine antagonists-blocks dopamine (remember excess for schizo) No effect on negative symptoms, so used less often
Less expensive
-Do not treat negative symptoms. (w/drawn, lack of feeling, pleasure, interest. not motivated in ADLs) -block of dopamine receptors in motor area cause extrapyramidal side effects (EPSs) as well anticholinergic effects, retarded Indonesian,
Schizophrenia tx meds-Test 2
Three of the most common EPS s/e are: -acute dystonia=acute sustained contraction of muscles usually head & neck -akathisia=psychomotor restlessness evident as pacing or fidgeting, pronounced & distressing to pt -pseudoparkinsonism= parkinsons symp: tremors, reduced accessory movements, shuffling gait, stiff, drooling, masked expression, "pin rolling"
-Occulogyric-eyes are locked upward, painful -Torticollis neck muscles contracting involuntarily side to side (recording says head to side? )
-reduce dose amount -adding anti-Parkinson meds, esp centrally acting meds like: trihexyphenidyl (artane) & benztrophine & amantadine hydrochloride (Benadryl) -Most pt will develop tolerance after a few months
T ardive dyskinesia (T D): shows up mont hsyrs af t er -Face: prot ruding and rolling t ounge, spast ic f acial dist ort ion, smacking movement s. grimincing -Limbs: Choreic (rapid, purposeless), At het oid (slow, complex) -T runk:neck & shoulder movement s, dramat ic hip jerks, rocking
Schizophrenia tx meds-Test 2
20% >2 yrs -D/C of drug rarely relieves symptoms -best to catch early, will worsen w/ time -changes in appearance, provide support
Severe EPS, rare, can be f atal (renal f ailure, cardiac) -can occur 1st week but of ten occurs later, rapid progress over 2-3 days. -early detection is the key. d/c med tx symptoms
-Hyperpyrexia: cardinal featuretemp over 103 - Autonomic dysfunction; htn, tachycardia, diaphoresis, incontinence, elevated vitals, UR -delirium, stupor, coma -Severe extrapyramidal symptoms
increase pituitary secretion of prolactin causing amenorrhea (no period), Galactorrhea (milk flow) gynecomastia in men (man boobies)
Schizophrenia tx meds-Test 2
Anticholinerg ic Symptom
many tradiontional Antipsycs also block mucus secretentic receptors in internal organs, causing -Dry Mouth - blurred vision (usually abates in 1-2 weeks -Urinary retention -constipation -photo-sensitivity -sexual dysfunction
-non reactive puplis -dry mucus membranes -reduced or absent peristalsis (smooth muscle move) -unstable vitals -seizures -urinary retention LIFE THREATENING- EMERGANCY
constipation, hypotension, ortho-hypon, increased appetite insomnia, sedation, UR, weight gain
-high sedation + high ACH + low EPSs -high acetylcholine (acts as neurotransmitter) af f ect -low risk f or extrapyamidal symptoms -*Chlopromazine (Thorazine), Thioridazine (Mellarill)*
Schizophrenia tx meds-Test 2
Haldol Decanoate and Prolixin Decanoate: these "decanoates" are long acting dont have to take the medications every day, it helps with med adherence
-Serotonin-dopamine antagonists (5HT2A) -bind to dopamine receptors in the alembic system, therefore we do see motor side effects such as Tardive dyskinesia which is irreversible -target negative and positive symptoms
Schizophrenia tx meds-Test 2
-fewer to no EPS, and other motor side effects -target negative symptoms of psychosis as well as positive symptoms -tx mood disorders: bipolar, depression and anxiety -decreases suicidal behavior.
-weight gain, can happen in all, but more so. -Metabolic abnormalities: need to monitor blood sugars & related metabolic changes -serious side effects depending on med -more expensive
1 Week but takes seceral months to reach max ef f ect Brief dose on benzodiazepine may be given to help pt maintain control during that time
Common A-typical
-Airpiprazole (Abilify) -Quetiapine (Seroquel) -Clozapine (Clozaril) -Ziprasidone (Geodone) -Paliperidone (invegal) -Asenapine (Saphris) -Risperidone (Risperdal) -Olanzapine (Zyprexa)
Schizophrenia tx meds-Test 2
-A-typical Clozaril
-A-typical Risperidone
Metabolic disturbances weight gain higher w/
-risk for agranulocytosis: monitoring the CBC closely -other s/e= connvulsions/sezier , myocarditis -anticonvulsive may be given as a preventative measure & cardiac status & labs monitored
May cause EPS at higher doses observing f or a side ef f ect known as neuromalignant syndrome convulsions, myocardit is, ot her side ef f ect s. Monit oring t he CBC, maybe based on t he risk, ant iconvulsive may be a prevent at ive measure and also looking at t he cardiac st at us and all t he labs relat ed t o t hat .
Sedation higher w/
Schizophrenia tx meds-Test 2
-Lithium: Greater toxicity in African Amer than whites -Haloperidol: Same dose, but plasma concentrations 50% higher in Asians than in whites -Clozapine: Life-threatening s/e agranulocytosis, more prevalent in Ashkenazi Jews than others